 |
|
 |
Canada |
|
|
C-MAP Canadian Drug Benefit Plans Reference Guide 2006 Edition
Publication Date January 2006
Publisher Palmer DAngelo
Product Type Report
Pages not applicable
ISBN Number not applicable
Product Code PDA001
|
|
|
Summary
Ninety per cent of Canadians have some form of drug plan coverage. However, staying up-to-date with the policies and requirements of the various reimbursement schemes is a challenging but necessary requirement for gaining access to the multi-billion dollar Canadian market. This comprehensive reference guide is an essential tool for developing and maintaining a clear understanding of Canada's public and private sector drug plans.
The Canadian Market Access for Pharmaceuticals (C-MAP™) Canadian Drug Benefit Plans Reference Guide 2006 Edition provides detailed information on the policies and procedures of the ten provincial prescription drug programs and includes separate chapters on four federal drug programs. There are also detailed overviews of the Provincial Cancer Programs, the Patented Medicine Prices Review Board (PMPRB), the Canadian Coordinating Office for Health Technology Assessment (CCOHTA), Federal/ Provincial/ Territorial Initiatives and the private drug plans in Canada. An extensive section on the Common Drug Review provides a comprehensive description of the CDR process including CDR rationale for CEDAC decisions, time to decision tracking of submissions and CDR submission forms and templates available online. The executive summary provides essential facts on each of the drug plans in convenient tabular format.
This publication includes, but is not restricted to:
- Identification of each provincial plan or selected federal program
- Detailed description of each plan
- Identification of the governing acts and regulations
- Drug plan expenditures and use profile
- Formulary descriptions
- Summaries of processes and procedures for listing and approval
- Special authorization processes
- Reimbursement regulations and procedures
- Requirements for manufacturers' submissions to the Common Drug Review and directly to the provincial drug plans including generic products
- A description of the Special Drug Programs for each province
- Reporting structure within each province
- PDCI online version of C-MAP™ Canadian Drug Benefit Plans Reference Guide
- A glossary of terms
The new features of the 2006 Edition are:
- A Comprehensive Section on Provincial Cancer Programs
- A Listing Process Summary Table for Interchangeables including generic submission deadline dates (where applicable)
- An improved and more comprehensible section on submission requirements for CDR and non-CDR submissions
- An enhanced Private Payers Section
- A free trial of PDCI's Canadian Drug Claims Database
Subscribers to C-MAP™ Canadian Drug Benefit Plans Reference Guide 2006 Edition are provided with ongoing email updates to ensure the content is always current. Subscribers also receive unlimited password protected access to the online version of Canadian Drug Benefit Plans Reference Guide 2006 Edition including manufacturers' submission forms and templates. The online version of this publication can be accessed by anyone within the subscribing organization.
|
Content
|
|
|
